Tag: CIRSE 2025
DOORwaY90 clinical trial interim analysis demonstrates efficacy of Y-90 resin microspheres...
An interim analysis of the DOORwaY90 clinical trial has shown that yttrium-90 (Y-90) resin microspheres—SIR-Spheres (Sirtex)—using partition dosimetry, achieved high objective response rates and...
The greater good: Is it time DR and IR part ways?...
Enmeshed throughout most global training curricula, dual certification in diagnostic radiology (DR) and interventional radiology (IR) is commonplace, but is an extensive knowledge of...
OncoSil Medical announce positive preliminary PANCOSIL results
OncoSil Medical announce that the preliminary results of the PANCOSIL investigator-initiated study reveal that it is safe and feasible to deliver OncoSil by CT-guided...
First-in-human study demonstrates complete vascular occlusion with peripheral liquid embolic agent
“Our conclusion is: Amber is safe, efficacious and might change the way we technically embolise some of our indications today,” were the closing remarks...
Y-90 glass microspheres demonstrate cost-effectiveness over TACE in HCC
An economic analysis presented by Laura Crocetti (University of Pisa, Pisa, Italy) in collaboration with several Italian centres including the Bocconi University, University of...
CIRSE 2025: SAVE trial reports higher efficacy for Selution SLR DEB...
A first report from the SAVE prospective, multicentre, single-blinded randomised controlled trial of the Selution sustained limus release (SLR; Cordis) drug-eluting balloon (DEB) in...
Shape Memory Medical completes enrolment in EMBO-PMS registry
Shape Memory Medical today announced the completion of patient enrolment in the EMBO postmarket surveillance (EMBO-PMS) registry, the company’s prospective, multicentre registry of the...
Is cryoablation the pinnacle of IO’s de-escalation philosophy?
De-escalation is a principle applied in many fields throughout medicine to reduce the duration, dose and number of therapies a patient receives to preserve...
